Intuitive Surgical Reports Preliminary Fourth Quarter 2019 Results
Intuitive Surgical (NASDAQ: ISRG) recorded $1.28 billion in revenue in the fourth quarter, up 22% year over year, according to preliminary results released Thursday after the closing bell. Shares of the robotic surgery company were up 2.4% in after-hours trading on the news.
The company released the unaudited results so it could discuss them during its presentation at the 38th Annual J.P. Morgan Healthcare Conference next week. Intuitive Surgical plans to report full results, including earnings, on Jan. 23, 2020.
The overall revenue was buoyed by sales of instruments and accessories used on its da Vinci Surgical Systems, which increased 24% year over year. During the quarter, Intuitive Surgical gained Food and Drug Administration approval for the SynchroSeal instrument, which is used for grasping, dissection, sealing, and transection of tissue, and approval of the E-100 generator that powers the SynchroSeal and another instrument called the Vessel Sealer Extend.
Source Fool.com
